XML 17 R6.htm IDEA: XBRL DOCUMENT v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Oct. 02, 2016
Sep. 27, 2015
Cash flows from operating activities:    
Consolidated net income $ 320,548 $ 354,526
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation expense 65,433 52,774
Amortization of intangible assets 38,051 40,884
Share-based compensation expense 101,845 97,104
Accretion of debt discount 22,342 29,828
Incremental tax benefit related to share-based compensation (109,934) (121,703)
Deferred income tax expense 57,539 83,679
Cost-method investment gain, net   (15,482)
Change in fair value of contingent consideration   (6,449)
Other 5,190 6,178
Changes in operating assets and liabilities:    
Accounts receivable 4,999 (121,309)
Inventory (41,757) (43,598)
Prepaid expenses and other current assets 3,572 (4,982)
Other assets (6,060) (428)
Accounts payable (7,307) 49,532
Accrued liabilities (57,325) 23,884
Other long-term liabilities 9,949 (5,220)
Net cash provided by operating activities 407,085 419,218
Cash flows from investing activities:    
Purchases of available-for-sale securities (679,064) (713,862)
Sales of available-for-sale securities 406,286 335,351
Maturities of available-for-sale securities 148,290 189,929
Net cash paid for acquisitions (17,841) (35,226)
Net purchases of strategic investments 9,075 4,100
Purchases of property and equipment (178,353) (107,361)
Cash paid for intangible assets 11,490 275
Net cash used in investing activities (341,247) (335,544)
Cash flows from financing activities:    
Payments on financing obligations (70,522) (216,207)
Payments on acquisition related contingent consideration liability (29,200) (1,500)
Proceeds from issuance of debt 5,000  
Incremental tax benefit related to share-based compensation 109,934 121,703
Common stock repurchases (113,075) (72,256)
Taxes paid related to net share settlement of equity awards (76,365) (95,157)
Proceeds from issuance of common stock 47,156 65,668
Proceeds from early exercise of equity awards from a subsidiary 5,851  
Contributions from noncontrolling interest owners 80,000 32,128
Net cash used in financing activities (41,221) (165,621)
Effect of exchange rate changes on cash and cash equivalents 1,310 (2,678)
Net increase (decrease) in cash and cash equivalents 25,927 (84,625)
Cash and cash equivalents at beginning of period 768,770 636,154
Cash and cash equivalents at end of period $ 794,697 $ 551,529